Genetic Testing for Rare Diseases: A Systematic Review of Ethical Aspects

被引:10
作者
Kruse, Judith [1 ]
Mueller, Regina [2 ]
Aghdassi, Ali A. [3 ]
Lerch, Markus M. [4 ]
Salloch, Sabine [5 ]
机构
[1] Univ Med Greifswald, Inst Eth & Hist Med, Greifswald, Germany
[2] Univ Tubingen, Inst Eth & Hist Med, Fac Med, Tubingen, Germany
[3] Univ Med Greifswald, Dept Med A, Greifswald, Germany
[4] LMU Munich Univ Hosp, Munich, Germany
[5] Hannover Med Sch, Inst Eth Hist & Philosophy Med, Hannover, Germany
关键词
genetic testing; rare diseases; orphan diseases; genetic councelling; ethics; HUNTINGTONS-DISEASE; ISSUES; DISCRIMINATION; DISORDERS; FAMILIES; GENOMICS; RISK;
D O I
10.3389/fgene.2021.701988
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Genetic testing is associated with many ethical challenges on the individual, organizational and macro level of health care systems. The provision of genetic testing for rare diseases in particular requires a full understanding of the complexity and multiplicity of related ethical aspects. This systematic review presents a detailed overview of ethical aspects relevant to genetic testing for rare diseases as discussed in the literature. The electronic databases Pubmed, Science Direct and Web of Science were searched, resulting in 55 relevant publications. From the latter, a total of 93 different ethical aspects were identified. These ethical aspects were structured into three main categories (process of testing, consequences of the test outcome and contextual challenges) and 20 subcategories highlighting the diversity and complexity of ethical aspects relevant to genetic testing for rare diseases. This review can serve as a starting point for the further in-depth investigation of particular ethical issues, the education of healthcare professionals regarding this matter and for informing international policy development on genetic testing for rare diseases.
引用
收藏
页数:14
相关论文
共 47 条
  • [1] Beauchamp T.L., 2019, PRINCIPLES BIOMEDICA, V8th ed.
  • [2] Orphan tests
    Biesecker, LG
    [J]. CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS, 1996, 5 (02) : 300 - 306
  • [3] Rare-disease genetics in the era of next-generation sequencing: discovery to translation
    Boycott, Kym M.
    Vanstone, Megan R.
    Bulman, Dennis E.
    MacKenzie, Alex E.
    [J]. NATURE REVIEWS GENETICS, 2013, 14 (10) : 681 - 691
  • [4] Axons to Exons: the Molecular Diagnosis of Rare Neurological Diseases by Next-Generation Sequencing
    Chardon, Jodi Warman
    Beaulieu, Chandree
    Hartley, Taila
    Boycott, Kym M.
    Dyment, David A.
    [J]. CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2015, 15 (09)
  • [5] Council of Europe, 1997, 164 ETS COUNC EUR
  • [6] International genetic testing
    Cox, SM
    Faucett, WA
    Chen, B
    Dequeker, E
    Boone, DJ
    McGovern, MM
    Lubin, IM
    [J]. GENETICS IN MEDICINE, 2003, 5 (03) : 176 - 182
  • [7] Next-generation sequencing applied to rare diseases genomics
    Danielsson, Krissi
    Mun, Liew Jun
    Lordemann, Amanda
    Mao, Jimmy
    Lin, Cheng-Ho Jimmy
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2014, 14 (04) : 469 - 487
  • [8] Ethical issues in haemophilia
    Dimichele, D
    Chuansumrit, A
    London, AJ
    Thompson, AR
    Cooper, CG
    Killian, RM
    Ross, LF
    Lillicrap, D
    Kimmelman, J
    [J]. HAEMOPHILIA, 2006, 12 : 30 - 35
  • [9] Genetic testing for hereditary pancreatitis: Guidelines for indications, counselling, consent and privacy issues
    Ellis, I
    Lerch, MM
    Whitcomb, DC
    [J]. PANCREATOLOGY, 2001, 1 (05) : 405 - 415
  • [10] European Union, 2008, COMM COMM EUR PARL C, P679